Hypertension: LCZ696, a novel dual inhibitor of neprilysin and the angiotensin II receptor, shows promise in phase II trial

Nat Rev Nephrol. 2010 Jul;6(7):383. doi: 10.1038/nrneph.2010.72.
No abstract available

Publication types

  • Comment